Vinci Pharmaceuticals, EPIPLANT, VCI-002, Series A Financing, Ophthalmology, Retinal Diseases, Drug Delivery, Sustained-Release Drug Delivery, Episcleral Implant, GMP Manufacturing

Avon-by-the-Sea, New Jersey, U.S., October 8, 2026 Vinci Pharmaceuticals Inc. has closed an over $8 million Series A financing...